Paper4621265
Cyclophosphamide: use in practice.
Gershwin ME and 2 others. Ann Intern Med, 1974. Cited by 172 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cyclophosphamide: use in practice. Papers, record 4621265. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4621265
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclophosphamide | Major topic |
| Animals | |
| Antineoplastic Agents | |
| Arthritis, Rheumatoid | |
| Cell Division | |
| Disease Models, Animal | |
| Humans | |
| Immunosuppressive Agents | |
| Infertility |
Source PubMed
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 172 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,283,991 | Isolation, Structural Characterization, and Potent Leishmanicidal, Anti-Cancer, and Anti-Microbial Activities of a New Diosgenin Glycoside from Malvastrum coromandelianum. | Appl Biochem Biotechnol | 2026 | https://conductscience.org/library/papers/42283991 | PubMed |
| 40,933,795 | Exploring the Interaction Between Sjögren's Syndrome and Osteoporosis: Pathophysiological Mechanisms and Management Strategies. | Int J Gen Med | 2025 | https://conductscience.org/library/papers/40933795 | PubMed |
| 40,918,309 | Hepatoprotective role of verbenone against cyclophosphamide-induced oxidative stress, inflammation, apoptosis, and fibrosis in Swiss albino mice: insights into the involvement of NF-κB, caspase-3, and TGF-β signaling pathways. | 3 Biotech | 2025 | https://conductscience.org/library/papers/40918309 | PubMed |
| 40,227,572 | From Bench to Bedside: Translational Approaches to Cardiotoxicity in Breast Cancer, Lung Cancer, and Lymphoma Therapies. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40227572 | PubMed |
| 38,592,504 | Coadministration of doxorubicin with vitamin D3, Lactobacillus acidophilus, and Lactobacillus casei in the 4T1 mouse model of breast cancer: anticancer and enteroprotective effects. | Med Oncol | 2024 | https://conductscience.org/library/papers/38592504 | PubMed |
| 38,372,853 | A Comprehensive Review of Cancer Drug-Induced Cardiotoxicity in Blood Cancer Patients: Current Perspectives and Therapeutic Strategies. | Curr Treat Options Oncol | 2024 | https://conductscience.org/library/papers/38372853 | PubMed |
| 37,806,986 | Drug-microbiota interactions: an emerging priority for precision medicine. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37806986 | PubMed |
| 35,610,338 | Molecular relation between biological stress and carcinogenesis. | Mol Biol Rep | 2022 | https://conductscience.org/library/papers/35610338 | PubMed |
| 34,540,917 | Severe Cardiac Toxicity Induced by Cancer Therapies Requiring Intensive Care Unit Admission. | Front Cardiovasc Med | 2021 | https://conductscience.org/library/papers/34540917 | PubMed |
| 34,361,007 | Mechanisms of Immunotoxicity: Stressors and Evaluators. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34361007 | PubMed |
| 32,309,607 | Therapy-induced cardiotoxicity in breast cancer patients: a well-known yet unresolved problem. | Discoveries (Craiova) | 2019 | https://conductscience.org/library/papers/32309607 | PubMed |
| 31,384,135 | Cancer Therapy-Related Cardiac Dysfunction: An Overview for the Clinician. | Clin Med Insights Cardiol | 2019 | https://conductscience.org/library/papers/31384135 | PubMed |
| 28,785,479 | Cancer and Heart Failure: Understanding the Intersection. | Card Fail Rev | 2017 | https://conductscience.org/library/papers/28785479 | PubMed |
| 28,610,894 | Mangiferin protects rat myocardial tissue against cyclophosphamide induced cardiotoxicity. | J Ayurveda Integr Med | 2017 | https://conductscience.org/library/papers/28610894 | PubMed |
| 26,966,633 | In Vivo Growing of New Cell Colonies in a Portion of Bone Marrow: Potential Use for Indirect Cell Therapy. | Cell Med | 2010 | https://conductscience.org/library/papers/26966633 | PubMed |
| 26,747,861 | Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging. | Circ Heart Fail | 2016 | https://conductscience.org/library/papers/26747861 | PubMed |
| 26,309,419 | Getting to the Heart of the Matter: An Overview of Cardiac Toxicity Related to Cancer Therapy. | Clin Med Insights Cardiol | 2015 | https://conductscience.org/library/papers/26309419 | PubMed |
| 22,203,433 | The future of autoimmunity. | Clin Rev Allergy Immunol | 2012 | https://conductscience.org/library/papers/22203433 | PubMed |
| 21,887,609 | Cutting-edge issues in organ-specific autoimmunity. | Clin Rev Allergy Immunol | 2011 | https://conductscience.org/library/papers/21887609 | PubMed |
| 21,358,666 | Explosion of autoimmune diseases and the mosaic of old and novel factors. | Cell Mol Immunol | 2011 | https://conductscience.org/library/papers/21358666 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4621265
GET https://conductscience.org/api/papers/v1/4621265/cited_by?page=2